CollPlant Biotechnologies... (CLGN)

NASDAQ: CLGN · Real-Time Price · USD

2.18

0.06 (2.83%)

At close: May 01, 2025, 3:50 PM

2.18

0.00%

After-hours: May 01, 2025, 04:05 PM EDT

2.83% (1D)

Bid	2.1
Market Cap	24.97M
Revenue (ttm)	515K
Net Income (ttm)	-16.61M
EPS (ttm)	-1.45
PE Ratio (ttm)	-1.5
Forward PE	70.33
Analyst	Buy

Ask	2.25
Volume	2,277
Avg. Volume (20D)	10,027
Open	2.11
Previous Close	2.12
Day's Range	2.10 - 2.19
52-Week Range	2.00 - 6.75
Beta	0.74

About CLGN

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and...

[Read more]

Industry Biotechnology

Sector Healthcare

IPO Date Jan 31, 2018

Employees 57

Stock Exchange NASDAQ

Ticker Symbol CLGN

Website https://www.collplant.com

Full Company Profile

Analyst Forecast

According to 3 analyst ratings, the average rating for CLGN stock is "Buy." The 12-month stock price forecast is $14, which is an increase of 542.20% from the latest price.

Stock Forecasts

Next Earnings Release

CollPlant Biotechnologies Ltd. is scheduled to release its earnings on May 28, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

5 months ago

-0.23%

CollPlant Biotechnologies shares are trading lower... Unlock content with Pro Subscription

News

1 month ago · seekingalpha.com

CollPlant Biotechnologies Ltd. (CLGN) Q4 2024 Earnings Call Transcript

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN ) Q4 2024 Earnings Conference Call March 26, 2025 10:00 AM ET Company Participants Dory Kurowski - LifeSci Advisors Yehiel Tal - CEO Eran Rotem - Deputy CEO...